MedPath

Intervertebral disc therapy using PRP-releasate

Phase 3
Conditions
low back pain
Registration Number
JPRN-UMIN000038536
Lead Sponsor
Mie University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
17
Inclusion Criteria

Not provided

Exclusion Criteria

Having remarkable cauda equine and neuropathy symptom Having systematic or spinal infection Past-history of lumbar surgeries Past-history of interventional intervertebral disc therapy Having intervertebral instability evaluated by lumbar radiograph Patients having spondylolisthesis (more than grade I by Meyerding classification) Having neuro-muscular diseases, cerebral diseases, malignant tumor and blood coagulation disorders High risk for infectious diseases after the treatment Having anti-coagulant drugs at the time of treatment Pregnant patient Difficulty in participating throughout the evaluation period More than 10-points of BS-POS questionnaire test Contraindication for MRI Inappropriate patient for clinical study evaluate by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in VAS (Visual Analogue Scale) at 8 weeks after the injection from VAS at baseline
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath